These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 19322169

  • 1. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
    Wise LE, Thorpe AJ, Lichtman AH.
    Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
    [Abstract] [Full Text] [Related]

  • 2. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.
    Brain Res; 2008 Jan 10; 1188():157-64. PubMed ID: 18021759
    [Abstract] [Full Text] [Related]

  • 3. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats.
    Robinson L, McKillop-Smith S, Ross NL, Pertwee RG, Hampson RE, Platt B, Riedel G.
    Psychopharmacology (Berl); 2008 Jul 10; 198(4):551-63. PubMed ID: 18049812
    [Abstract] [Full Text] [Related]

  • 4. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats.
    Lichtman AH, Dimen KR, Martin BR.
    Psychopharmacology (Berl); 1995 Jun 10; 119(3):282-90. PubMed ID: 7675962
    [Abstract] [Full Text] [Related]

  • 5. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 10; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
    DeLong GT, Wolf CE, Poklis A, Lichtman AH.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):126-33. PubMed ID: 20619971
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
    Nava F, Carta G, Colombo G, Gessa GL.
    Neuropharmacology; 2001 Sep 01; 41(3):392-9. PubMed ID: 11522331
    [Abstract] [Full Text] [Related]

  • 8. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
    Sousa VC, Assaife-Lopes N, Ribeiro JA, Pratt JA, Brett RR, Sebastião AM.
    Neuropsychopharmacology; 2011 Jan 01; 36(2):472-87. PubMed ID: 20927050
    [Abstract] [Full Text] [Related]

  • 9. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
    Lichtman AH, Martin BR.
    Psychopharmacology (Berl); 1996 Jul 01; 126(2):125-31. PubMed ID: 8856831
    [Abstract] [Full Text] [Related]

  • 10. delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
    Wise LE, Varvel SA, Selley DE, Wiebelhaus JM, Long KA, Middleton LS, Sim-Selley LJ, Lichtman AH.
    Psychopharmacology (Berl); 2011 Oct 01; 217(4):485-94. PubMed ID: 21559804
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats.
    Hampson RE, Deadwyler SA.
    J Neurosci; 2000 Dec 01; 20(23):8932-42. PubMed ID: 11102504
    [Abstract] [Full Text] [Related]

  • 12. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH, Martin BR.
    Pharmacol Biochem Behav; 1997 Dec 01; 57(1-2):7-12. PubMed ID: 9164547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
    Wiley JL, Matthew Walentiny D, Vann RE, Baskfield CY.
    Behav Pharmacol; 2011 Sep 01; 22(5-6):480-8. PubMed ID: 21712709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR.
    J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1211-8. PubMed ID: 16943255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.